Comparing Two Malaria Treatments in Children
Author Information
Author(s): Mens Petra F, Sawa Patrick, van Amsterdam Sandra M, Versteeg Inge, Omar Sabah A, Schallig Henk DFH, Kager Piet A
Primary Institution: Koninklijk Instituut voor de Tropen (KIT)
Hypothesis
How do artemether-lumefantrine and dihydroartemisinin-piperaquine compare in treating uncomplicated malaria and controlling transmission?
Conclusion
Both treatments were effective, but artemether-lumefantrine showed better gametocyte clearance compared to dihydroartemisinin-piperaquine.
Supporting Evidence
- The study included 146 children diagnosed with uncomplicated malaria.
- Gametocyte clearance was significantly better with artemether-lumefantrine compared to dihydroartemisinin-piperaquine.
- Both treatments were well tolerated with no significant adverse events reported.
Takeaway
The study looked at two malaria treatments for kids and found that one worked better at getting rid of the malaria germs.
Methodology
A two-arm randomized controlled trial with 146 children treated with either AL or DP, followed for 28 days.
Potential Biases
There may be bias in treatment allocation and reporting of outcomes.
Limitations
The study was limited by the small sample size and the potential for loss to follow-up.
Participant Demographics
Children aged 6 months to 12 years with uncomplicated malaria.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website